News & Press Releases

An article published by The American Lawyer spotlighted law firm pro bono efforts during the COVID-19 pandemic, including Mintz’s initiative as part of a $9 million eviction legal aid project in Massachusetts to recruit 21 law firms and corporate legal departments to provide pro bono counsel to tenants facing eviction

Mintz Member and Co-chair of the firm’s Life Sciences Practice William Whelan was quoted in an article published by Fierce Pharma discussing the findings of a Mintz / Mergermarket report, which provides insight into recent M&A activity and market views, as well as interesting comparatives to the previous year.

Law360 covered Mintz Member LisaMarie Collins participation in the ACC Foundation’s Global Women in Law & Leadership Virtual Conference. Her session, "Diversifying the Board Room – Women Lawyers Leading the Way,” addressed the changing landscape of the board room which was previously thought to be out of reach for lawyers - and women in particular.

Mintz Member Kelly Frey was featured by Law360 as among the publication’s 2021 Rising Stars in the Real Estate category.

Mintz Member and Co-chair of the firm’s Insurance Practice Nancy Adams was quoted extensively in an article published by Thomson Reuters Regulatory Intelligence detailing how companies going public through a merger with a special purpose acquisition company, or SPAC, are facing skyrocketing premiums for directors and officers’ liability coverage due to the higher risk of litigation and increased regulatory scrutiny. The article also quoted remarks made by Of Counsel Kristen White during a recent Mintz webinar exploring the rising risk of litigation and regulatory enforcement facing SPACs and the individuals that lead them.

Mintz Member and Co-chair of the firm’s Product Liability Practice Joseph G. Blute was quoted in an article published by Law360 that provided analysis on a recent ruling from the U.S. District Court for the District of Massachusetts granting summary judgment to pharmaceutical company GlaxoSmithKline in a lawsuit alleging that its anti-nausea medication Zofran causes birth defects. Mr. Blute was among legal sources to comment on how the preemption ruling provides a "roadmap" for fending off multidistrict litigation with the help of a landmark U.S. Supreme Court ruling, Merck v. Albrecht.